These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6086247)

  • 1. Efficacy of cefotaxime and latamoxef for Escherichia coli bacteremia and meningitis in newborn rats.
    Kim KS; Manocchio M; Bayer AS
    Chemotherapy; 1984; 30(4):262-9. PubMed ID: 6086247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of cefmenoxime in experimental Escherichia coli bacteremia and meningitis.
    Kim KS
    Antimicrob Agents Chemother; 1985 Sep; 28(3):389-92. PubMed ID: 3907491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of trimethoprim/sulfamethoxazole in experimental Escherichia coli bacteremia and meningitis.
    Kim KS; Anthony BF
    Chemotherapy; 1983; 29(6):428-35. PubMed ID: 6360577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci.
    Kim KS; Bayer AS
    Antimicrob Agents Chemother; 1985 Jul; 28(1):51-4. PubMed ID: 3899006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cefotaxime, imipenem-cilastatin, ampicillin-gentamicin, and ampicillin-chloramphenicol in the treatment of experimental Escherichia coli bacteremia and meningitis.
    Kim KS
    Antimicrob Agents Chemother; 1985 Sep; 28(3):433-6. PubMed ID: 3907493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment failures of cefotaxime and latamoxef in meningitis caused by Enterobacter and Serratia spp.
    Eng RH; Cherubin CE; Pechere JC; Beam TR
    J Antimicrob Chemother; 1987 Dec; 20(6):903-11. PubMed ID: 3501999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of imipenem in experimental group B streptococcal bacteremia and meningitis.
    Kim KS
    Chemotherapy; 1985; 31(4):304-9. PubMed ID: 3896683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone therapy of group B streptococcal bacteraemia and meningitis in infant rats.
    Delaplane D; Yogev R; Shulman ST
    J Antimicrob Chemother; 1983 Jan; 11(1):69-73. PubMed ID: 6298176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradox between the responses of Escherichia coli K1 to ampicillin and chloramphenicol in vitro and in vivo.
    Kim KS; Manocchio M; Anthony BF
    Antimicrob Agents Chemother; 1984 Nov; 26(5):689-93. PubMed ID: 6393867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditis.
    Contrepois A; Vallois JM; Garaud JJ; Pangon B; Mohler J; Meulemans A; Carbon C
    J Antimicrob Chemother; 1986 Feb; 17(2):227-37. PubMed ID: 3516963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of gram-negative bacilli from meningitis patients who failed or relapsed on moxalactam therapy.
    Eng RH; Cherubin C; Smith SM; Buccini F
    Antimicrob Agents Chemother; 1984 Dec; 26(6):850-6. PubMed ID: 6395799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with the use of cefotaxime in the treatment of bacterial meningitis.
    Cherubin CE; Eng RH
    Am J Med; 1986 Mar; 80(3):398-404. PubMed ID: 3513559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Importance of the study of the minimal bactericidal time of serum in the choice of optimal treatment of neonatal septicemias].
    Bingen E; Lambert-Zechovsky N; Guihaire E; Mariani P; Coache M; Jacqz E; Aujard Y; Mathieu H
    Pathol Biol (Paris); 1987 May; 35(5):599-602. PubMed ID: 3302866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis.
    Decazes JM; Ernst JD; Sande MA
    Antimicrob Agents Chemother; 1983 Oct; 24(4):463-7. PubMed ID: 6316841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of MT-141, a new cephamycin antibiotic, on acute urinary tract infections.
    Miyamoto S; Tamiya T; Takatsuka K; Kumamoto Y
    Drugs Exp Clin Res; 1985; 11(6):379-82. PubMed ID: 3939123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of cefmenoxime in experimental group B streptococcal bacteraemia and meningitis.
    Kim KS
    J Antimicrob Chemother; 1986 Feb; 17(2):239-44. PubMed ID: 3516964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of cefotaxime and moxalactam into cerebrospinal fluid of rabbits with experimentally induced Escherichia coli meningitis.
    Nolan CM; Ulmer C
    Rev Infect Dis; 1982; 4 Suppl():S396-400. PubMed ID: 6294789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic studies of cefepime (BMY 28142) in murine meningitis and pharmacokinetics in neonatal rats.
    Tsai YH; Bies M; Leitner F; Kessler RE
    Antimicrob Agents Chemother; 1990 May; 34(5):733-8. PubMed ID: 2360814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal cefotaxime dosing for gram-negative bacteremia: effective trough serum bactericidal titers and drug concentrations 8 and 12 hr after 1- or 2-gm infusions.
    Goodpasture HC; Gerlach EH; Jones RN; Peterie JD
    Diagn Microbiol Infect Dis; 1988 Feb; 9(2):97-103. PubMed ID: 3383550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of gentamicin and kanamycin alone and in combination with ampicillin in experimental Escherichia coli bacteremia and meningitis.
    Kim KS
    Pediatr Res; 1985 Nov; 19(11):1152-5. PubMed ID: 3906546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.